Historical record - last NADAC effective date: 1/4/2019
Product Information
NOXAFIL 40 MG/ML SUSPENSION is a brand product labeled by Merck Sharp & Dohme LLC, priced at $13.3669 per ML under NDC 00085132801. Its NADAC has been published 321 times since Nov 28, 2013.
FDA first approved this application on Sep 15, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the posaconazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/mL
Manufacturer
Merck Sharp & Dohme LLCNDC
00085132801
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
1/4/2019
Active Ingredients
POSACONAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA022003FDA Approved
9/15/2006
TE Code
AB
On Market Since
9/15/2006
Pharmacological Classes
Price Statistics
The NADAC for NOXAFIL 40 MG/ML SUSPENSION has been published 321 times since Nov 28, 2013, and over the history we have for it it has risen 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.3669 per ML |
|---|---|
| All-time high | $13.3669 (Jan 15, 2020) |
| All-time low | $8.8163 (Nov 28, 2013) |
| Median price | $11.7643 |
| Average price | $11.6575 |
| Largest weekly change | +9.9% (Feb 4, 2015) |
| Weeks tracked | 321 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+51.6%
Last surveyed Jan 15, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the posaconazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NOXAFIL 40 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for NOXAFIL 40 MG/ML SUSPENSION, manufactured by Merck Sharp & Dohme LLC, is $13.3669 per ML (NDC 00085132801), effective Jan 15, 2020.
How has the price of NOXAFIL 40 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for NOXAFIL 40 MG/ML SUSPENSION has risen 51.6%. It has been tracked across 321 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NOXAFIL 40 MG/ML SUSPENSION?
Since Nov 28, 2013, the NADAC for NOXAFIL 40 MG/ML SUSPENSION has ranged from a low of $8.8163 (Nov 28, 2013) to a high of $13.3669 (Jan 15, 2020), with a median of $11.7643 per ML.
Are there cheaper alternatives to NOXAFIL 40 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of NOXAFIL 40 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NOXAFIL 40 MG/ML SUSPENSION?
NOXAFIL 40 MG/ML SUSPENSION (NDC 00085132801) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.